Hodgkin's Lymphoma

Hodgkin's Lymphoma News

  • Seattle Genetics Halts Late-stage Study of Leukemia Drug Seattle Genetics Inc said it would halt a late-stage study of its drug to treat a type of leukemia in older patients following a "higher rate" of deaths in patients on the drug compared with those on a placebo.
  • Hodgkin's Tx Intensity Can Be Spared With Negative PET Patients with advanced Hodgkin's lymphoma who show early metabolic response on FDG-PET scans can safely and effectively be switched to a reduced chemotherapy regimen, say researchers.
 

Hodgkin's Lymphoma Perspective

 

Journals